Aug 12 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O:
AMPHASTAR PHARMACEUTICALS INC - ON AUGUST 8, ENTERED LICENSE AGREEMENT WITH NANJING ANJI BIOTECHNOLOGY - SEC FILING
AMPHASTAR PHARMACEUTICALS INC - TO PAY UP TO $267 MILLION IN MILESTONE PAYMENTS - SEC FILING
AMPHASTAR PHARMACEUTICALS INC - PAYS $6 MILLION TO ANJI UPON AGREEMENT SIGNING - SEC FILING